JP2010514842A5 - - Google Patents

Download PDF

Info

Publication number
JP2010514842A5
JP2010514842A5 JP2009544958A JP2009544958A JP2010514842A5 JP 2010514842 A5 JP2010514842 A5 JP 2010514842A5 JP 2009544958 A JP2009544958 A JP 2009544958A JP 2009544958 A JP2009544958 A JP 2009544958A JP 2010514842 A5 JP2010514842 A5 JP 2010514842A5
Authority
JP
Japan
Prior art keywords
benzamide
benzyl
tetrahydro
dimethoxy
ylcarbamoyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009544958A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010514842A (ja
JP5258790B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/050014 external-priority patent/WO2008086047A1/en
Publication of JP2010514842A publication Critical patent/JP2010514842A/ja
Publication of JP2010514842A5 publication Critical patent/JP2010514842A5/ja
Application granted granted Critical
Publication of JP5258790B2 publication Critical patent/JP5258790B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009544958A 2007-01-03 2008-01-02 Rhoキナーゼインヒビター Expired - Fee Related JP5258790B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US87862507P 2007-01-03 2007-01-03
US60/878,625 2007-01-03
PCT/US2008/050014 WO2008086047A1 (en) 2007-01-03 2008-01-02 Rho kinase inhibitors

Publications (3)

Publication Number Publication Date
JP2010514842A JP2010514842A (ja) 2010-05-06
JP2010514842A5 true JP2010514842A5 (enExample) 2011-02-24
JP5258790B2 JP5258790B2 (ja) 2013-08-07

Family

ID=39313484

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009544958A Expired - Fee Related JP5258790B2 (ja) 2007-01-03 2008-01-02 Rhoキナーゼインヒビター

Country Status (8)

Country Link
US (1) US8093266B2 (enExample)
EP (1) EP2114869B1 (enExample)
JP (1) JP5258790B2 (enExample)
AR (1) AR064726A1 (enExample)
CA (1) CA2674389A1 (enExample)
CL (1) CL2007003874A1 (enExample)
TW (1) TW200843770A (enExample)
WO (1) WO2008086047A1 (enExample)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0721333D0 (en) * 2007-10-31 2007-12-12 Motac Neuroscience Ltd Medicaments
JPWO2010024258A1 (ja) * 2008-08-29 2012-01-26 塩野義製薬株式会社 Pi3k阻害活性を有する縮環アゾール誘導体
US20120225862A1 (en) * 2009-07-21 2012-09-06 Auckland Univservices Limited Heteroaryl benzamides, compositions and methods of use
US9126978B2 (en) 2009-11-17 2015-09-08 The Regents Of The University Of Michigan 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties
CN102753527B (zh) * 2010-02-02 2014-12-24 诺华股份有限公司 用作crf受体拮抗剂的环己基酰胺衍生物
US8697911B2 (en) * 2010-07-07 2014-04-15 Boehringer Ingelheim International Gmbh Rho kinase inhibitors
US9079880B2 (en) * 2010-07-07 2015-07-14 Boehringer Ingelheim International Gmbh Rho kinase inhibitors
WO2012054367A1 (en) * 2010-10-19 2012-04-26 Boehringer Ingelheim International Gmbh Rho kinase inhibitors
RU2013126657A (ru) 2010-11-15 2014-12-27 Эббви Инк. Ингибиторы nampt и rock
US9029370B2 (en) * 2011-06-10 2015-05-12 Hoffmann-La Roche Inc. Substituted benzamide derivatives
JP6050238B2 (ja) 2011-10-19 2016-12-21 興和株式会社 新規なスピロインドリン化合物、及びそれを含有する医薬
US9204645B2 (en) 2011-12-20 2015-12-08 Bayer Intellectual Property Gmbh Insecticidal aromatic amides
CN104812382A (zh) 2012-09-20 2015-07-29 坦普尔大学 取代的烷基二芳基衍生物、制备方法和用途
CA2898440A1 (en) 2013-01-18 2014-07-24 Bristol-Myers Squibb Company Phthalazinones and isoquinolinones as rock inhibitors
WO2014177699A1 (en) * 2013-05-03 2014-11-06 INSERM (Institut National de la Santé et de la Recherche Médicale) Rhoa (rock) inhibitors for the treatment of enflammatory bowel disease
US9902702B2 (en) 2014-07-15 2018-02-27 Bristol-Myers Squibb Company Spirocycloheptanes as inhibitors of rock
CN107108581B (zh) 2014-08-21 2020-06-23 百时美施贵宝公司 作为强效rock抑制剂的回接苯甲酰胺衍生物
JP6883173B2 (ja) 2015-05-12 2021-06-09 ヘモストッド エスエー 改善された血小板産生のための薬理学的特徴およびマイクロ流体特徴の組み合わせ
EP3307725A1 (en) 2015-06-11 2018-04-18 Basilea Pharmaceutica International AG Efflux-pump inhibitors and therapeutic uses thereof
CN105195114B (zh) * 2015-10-29 2017-08-25 重庆郑博生物科技有限公司 脓毒症多种致病因子的吸附材料及其制备方法和用途
AR107354A1 (es) 2016-01-13 2018-04-18 Bristol Myers Squibb Co Salicilamidas espiroheptanos y compuestos relacionados como inhibidores de rock
CN109661396B (zh) 2016-07-07 2022-07-01 百时美施贵宝公司 作为rock抑制剂的螺稠合环状脲
WO2018108156A1 (zh) * 2016-12-16 2018-06-21 成都先导药物开发有限公司 Rock抑制剂及其应用
JP7234201B2 (ja) 2017-07-12 2023-03-07 ブリストル-マイヤーズ スクイブ カンパニー 心不全の治療のためのrockの5員アミノヘテロ環および5,6-または6,6員二環式アミノヘテロ環の阻害剤
EP3652164B1 (en) 2017-07-12 2023-06-21 Bristol-Myers Squibb Company Phenylacetamides as inhibitors of rock
TW201908293A (zh) 2017-07-12 2019-03-01 美商必治妥美雅史谷比公司 作為rock抑制劑之5員及雙環雜環醯胺
CN110914257B (zh) 2017-07-12 2023-05-26 百时美施贵宝公司 作为rock抑制剂的螺庚基乙内酰脲
US12281308B2 (en) 2018-08-29 2025-04-22 University Of Massachusetts Inhibition of protein kinases to treat Friedreich ataxia
US20250074904A1 (en) * 2021-11-17 2025-03-06 The University Of North Carolina At Chapel Hill Nsd2-targeted checmical degraderts and compositions and methods of use thereof
WO2024076155A1 (ko) * 2022-10-04 2024-04-11 노보렉스 주식회사 Yeats 도메인 억제제로서 신규한 화합물

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2170730C2 (ru) * 1996-05-20 2001-07-20 Дарвин Дискавери Лимитед Хинолиновые карбоксамиды и фармацевтическая композиция на их основе
JPH11139969A (ja) * 1997-08-07 1999-05-25 Tanabe Seiyaku Co Ltd 医薬組成物
JPH11130751A (ja) * 1997-10-30 1999-05-18 Yoshitomi Pharmaceut Ind Ltd アミド化合物およびそれらの酸付加塩の標識化合物
US7217722B2 (en) * 2000-02-01 2007-05-15 Kirin Beer Kabushiki Kaisha Nitrogen-containing compounds having kinase inhibitory activity and drugs containing the same
US7199147B2 (en) 2001-06-12 2007-04-03 Dainippon Sumitomo Pharma Co., Ltd. Rho kinase inhibitors
DE10357510A1 (de) * 2003-12-09 2005-07-07 Bayer Healthcare Ag Heteroarylsubstituierte Benzole
WO2005074643A2 (en) * 2004-01-30 2005-08-18 Smithkline Beecham Corporation Benzamide compounds useful as rock inhibitors

Similar Documents

Publication Publication Date Title
JP2010514842A5 (enExample)
US7868001B2 (en) Cytokine inhibitors
JP5258790B2 (ja) Rhoキナーゼインヒビター
JP6511430B2 (ja) がんの治療のための化合物および組成物
AU2002226674B2 (en) Tricyclic and heterocyclic derivative compounds and drugs containing these compounds as the active ingredient
JP2012502986A5 (enExample)
CN108884061B (zh) 1,2,4-三嗪-3-胺类衍生物、其制备方法及其在医药上的应用
KR20090127307A (ko) 히스타민 h3 수용체 조절제로서의 테트라하이드로이소퀴놀린 화합물
JP2007521287A5 (enExample)
CA2578955A1 (en) Isoindolin-1-one derivatives
RU2007146462A (ru) Диарилгидантоины
AU2004272437A1 (en) CRF antagonists and heterobicyclic compounds
AU2008214372A1 (en) Therapeutic agents
RU2019136536A (ru) Ингибиторы гистондеацетилаз (hdac)
JP2005514398A5 (enExample)
JP2009523812A5 (enExample)
EP2464227A1 (en) Compounds and methods of use thereof
KR20130073908A (ko) 테트라하이드로벤조티오펜 화합물
JPH11171865A (ja) 縮合ヘテロ環化合物
JPH0641471B2 (ja) チエノトリアゾロジアゼピン化合物およびその医薬用途
IL269144B2 (en) Pyrrolotriazine derivatives as kinase inhibitors
AU2020298779A1 (en) Estrogen-related receptor alpha (ERRα) modulators
WO2008124524A2 (en) Aryl sulfonamide compounds as modulators of the cck2 receptor
JP2017119628A (ja) 置換アゾール化合物及び糖尿病治療薬
WO2019082910A1 (ja) バソプレシン受容体拮抗剤